Search research articles
Contact Us
Filters
Showing results (21-30 of 67) with videos related to
Page
of 7
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
August 10, 2000
Assessment of percutaneous fine needle aspiration cytology as a technique to provide diagnostic and prognostic information in neuroblastoma
P Thiesse, M A Hany, V Combaret, et al.
Bulletin Du Cancer
|
September 24, 2004
Can MIBG scan replace the need for bone marrow assessment at diagnosis and reassessment in stage 4 neuroblastomas?
D Frappaz, V Combaret, C Desuzinges, et al.
Cancer Research
|
June 1, 1992
Tumor necrosis factor as an autocrine growth factor for neuroblastoma
E Goillot, V Combaret, R Ladenstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1996
Clinical relevance of CD44 cell-surface expression and N-myc gene amplification in a multicentric analysis of 121 pediatric neuroblastomas
V Combaret, N Gross, C Lasset, et al.
Bulletin Du Cancer
|
January 1, 1992
[Analysis of changes in serum levels of TNF, IL-1 and IL-6 during administration of IL-2. Correlation with clinical response to treatment]
J Y Blay, S Négrier, V Combaret, et al.
Cancer Research
|
August 1, 1989
Correspondence re: John R. Yanelli et al., Enhancement of Human Lymphokine-activated Killer Cell Cytolysis and a Method for Increasing Lymphokine-activated Killer Cell Yields to Cancer Patients. Cancer Res., 48: 5696-5700, 1988
M C Favrot, C Coze, V Combaret, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 28, 1998
Clinical relevance of CD44 cell surface expression and MYCN gene amplification in neuroblastoma
V Combaret, N Gross, C Lasset, et al.
Bulletin Du Cancer
|
January 1, 1995
[CD44 expression: a new prognostic factor in neuroblastoma]
V Combaret, C Lasset, R Bouvier, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1995
Evaluation of CD44 prognostic value in neuroblastoma: comparison with the other prognostic factors
V Combaret, C Lasset, D Frappaz, et al.
International Journal of Cancer
|
April 10, 1995
Sensitive detection of numerical and structural aberrations of chromosome 1 in neuroblastoma by interphase fluorescence in situ hybridization. Comparison with restriction fragment length polymorphism and conventional cytogenetic analyses
V Combaret, C Turc-Carel, P Thiesse, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 67) with videos related to
Sort By:
Page
of 7
European Journal of Cancer (Oxford, England : 1990)
|
August 10, 2000
Assessment of percutaneous fine needle aspiration cytology as a technique to provide diagnostic and prognostic information in neuroblastoma
P Thiesse, M A Hany, V Combaret, et al.
Bulletin Du Cancer
|
September 24, 2004
Can MIBG scan replace the need for bone marrow assessment at diagnosis and reassessment in stage 4 neuroblastomas?
D Frappaz, V Combaret, C Desuzinges, et al.
Cancer Research
|
June 1, 1992
Tumor necrosis factor as an autocrine growth factor for neuroblastoma
E Goillot, V Combaret, R Ladenstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1996
Clinical relevance of CD44 cell-surface expression and N-myc gene amplification in a multicentric analysis of 121 pediatric neuroblastomas
V Combaret, N Gross, C Lasset, et al.
Bulletin Du Cancer
|
January 1, 1992
[Analysis of changes in serum levels of TNF, IL-1 and IL-6 during administration of IL-2. Correlation with clinical response to treatment]
J Y Blay, S Négrier, V Combaret, et al.
Cancer Research
|
August 1, 1989
Correspondence re: John R. Yanelli et al., Enhancement of Human Lymphokine-activated Killer Cell Cytolysis and a Method for Increasing Lymphokine-activated Killer Cell Yields to Cancer Patients. Cancer Res., 48: 5696-5700, 1988
M C Favrot, C Coze, V Combaret, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 28, 1998
Clinical relevance of CD44 cell surface expression and MYCN gene amplification in neuroblastoma
V Combaret, N Gross, C Lasset, et al.
Bulletin Du Cancer
|
January 1, 1995
[CD44 expression: a new prognostic factor in neuroblastoma]
V Combaret, C Lasset, R Bouvier, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1995
Evaluation of CD44 prognostic value in neuroblastoma: comparison with the other prognostic factors
V Combaret, C Lasset, D Frappaz, et al.
International Journal of Cancer
|
April 10, 1995
Sensitive detection of numerical and structural aberrations of chromosome 1 in neuroblastoma by interphase fluorescence in situ hybridization. Comparison with restriction fragment length polymorphism and conventional cytogenetic analyses
V Combaret, C Turc-Carel, P Thiesse, et al.
Page
of 7